Follow
Marco Bandini
Marco Bandini
Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Verified email at hsr.it
Title
Cited by
Cited by
Year
Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies
A Necchi, D Raggi, A Gallina, R Madison, M Colecchia, R Luciano, ...
European urology 77 (4), 439-446, 2020
2632020
Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer
G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ...
European urology 72 (4), 632-640, 2017
2142017
Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer
A Necchi, D Raggi, A Gallina, JS Ross, E Farè, P Giannatempo, ...
European urology 77 (6), 701-710, 2020
1452020
Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up
G Gandaglia, N Fossati, A Stabile, M Bandini, P Rigatti, F Montorsi, ...
European urology 72 (2), 289-292, 2017
1142017
Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings …
A Necchi, M Bandini, G Calareso, D Raggi, F Pederzoli, E Farè, ...
European urology 77 (5), 636-643, 2020
842020
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆
M Bandini, EA Gibb, A Gallina, D Raggi, L Marandino, M Bianchi, JS Ross, ...
Annals of Oncology 31 (12), 1755-1763, 2020
742020
Early postoperative radiotherapy is associated with worse functional outcomes in patients with prostate cancer
E Zaffuto, G Gandaglia, N Fossati, P Dell’Oglio, M Moschini, V Cucchiara, ...
The Journal of urology 197 (3 Part 1), 669-675, 2017
732017
Obesity and prostate cancer
M Bandini, G Gandaglia, A Briganti
Current Opinion in Urology 27 (5), 415-421, 2017
692017
Survival after cytoreductive nephrectomy in metastatic non-clear cell renal cell carcinoma patients: a population-based study
M Marchioni, M Bandini, F Preisser, Z Tian, A Kapoor, L Cindolo, ...
European urology focus 5 (3), 488-496, 2019
552019
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion
F Preisser, M Bandini, M Marchioni, S Nazzani, Z Tian, RS Pompe, ...
The Prostate 78 (6), 469-475, 2018
542018
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy
M Moschini, B Foerster, M Abufaraj, F Soria, T Seisen, M Roupret, P Colin, ...
World Journal of Urology 35, 1541-1547, 2017
482017
A global approach to improving penile cancer care
M Bandini, M Ahmed, G Basile, N Watkin, V Master, Y Zhu, G Prakash, ...
Nature reviews Urology 19 (4), 231-239, 2022
472022
Causal contributors to tissue stiffness and clinical relevance in urology
L Martinez-Vidal, V Murdica, C Venegoni, F Pederzoli, M Bandini, ...
Communications Biology 4 (1), 1011, 2021
472021
Local treatment for metastatic prostate cancer: a systematic review
D Tilki, RS Pompe, M Bandini, M Marchioni, A Kretschmer, Z Tian, ...
International Journal of Urology 25 (5), 390-403, 2018
462018
Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study
M Bandini, RS Pompe, M Marchioni, E Zaffuto, G Gandaglia, N Fossati, ...
International urology and nephrology 50, 71-78, 2018
462018
The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary pT2‐3 non‐metastatic renal cell carcinoma treated …
M Marchioni, M Bandini, RS Pompe, T Martel, Z Tian, SF Shariat, ...
BJU international 121 (3), 383-392, 2018
432018
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer
M Bandini, JS Ross, D Raggi, A Gallina, M Colecchia, R Lucianò, ...
JNCI: Journal of the National Cancer Institute 113 (1), 48-53, 2021
422021
Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages
RS Pompe, D Tilki, F Preisser, SR Leyh‐Bannurah, M Bandini, ...
The Prostate 78 (10), 753-757, 2018
422018
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial
G Basile, M Bandini, EA Gibb, JS Ross, D Raggi, L Marandino, ...
Clinical Cancer Research 28 (23), 5107-5114, 2022
402022
First North American validation and head‐to‐head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy
M Bandini, M Marchioni, RS Pompe, Z Tian, G Gandaglia, N Fossati, ...
BJU international 121 (4), 592-599, 2018
382018
The system can't perform the operation now. Try again later.
Articles 1–20